Your browser doesn't support javascript.
loading
Cardiovascular Toxicities of BTK Inhibitors in Chronic Lymphocytic Leukemia: JACC: CardioOncology State-of-the-Art Review.
Quartermaine, Cooper; Ghazi, Sanam M; Yasin, Aneeq; Awan, Farrukh T; Fradley, Michael; Wiczer, Tracy; Kalathoor, Sujay; Ferdousi, Mussammat; Krishan, Satyam; Habib, Alma; Shaaban, Adnan; Kola-Kehinde, Onaopepo; Kittai, Adam S; Rogers, Kerry A; Grever, Michael; Ruz, Patrick; Bhat, Seema; Dickerson, Tyler; Byrd, John C; Woyach, Jennifer; Addison, Daniel.
Afiliação
  • Quartermaine C; Cardio-Oncology Program, Division of Cardiology, The Ohio State University Medical Center, Columbus, Ohio, USA.
  • Ghazi SM; Cardio-Oncology Program, Division of Cardiology, The Ohio State University Medical Center, Columbus, Ohio, USA.
  • Yasin A; Cardio-Oncology Program, Division of Cardiology, The Ohio State University Medical Center, Columbus, Ohio, USA.
  • Awan FT; Division of Hematology, UT-Southwestern Medical Center, Dallas, Texas, USA.
  • Fradley M; Cardio-Oncology Program, Division of Cardiology, University of Pennsylvania, Philadelphia, Pennsylvania, USA.
  • Wiczer T; Department of Pharmacy, James Cancer Hospital and Solove Research Institute, Columbus, Ohio, USA.
  • Kalathoor S; Cardio-Oncology Program, Division of Cardiology, The Ohio State University Medical Center, Columbus, Ohio, USA.
  • Ferdousi M; Cardio-Oncology Program, Division of Cardiology, The Ohio State University Medical Center, Columbus, Ohio, USA.
  • Krishan S; Department of Medicine, University of Oklahoma Medical Center, Oklahoma City, Oklahoma, USA.
  • Habib A; Division of Hematology, The Ohio State University, Columbus, Ohio, USA.
  • Shaaban A; Cardio-Oncology Program, Division of Cardiology, The Ohio State University Medical Center, Columbus, Ohio, USA.
  • Kola-Kehinde O; Cardio-Oncology Program, Division of Cardiology, The Ohio State University Medical Center, Columbus, Ohio, USA.
  • Kittai AS; Division of Hematology, The Ohio State University, Columbus, Ohio, USA.
  • Rogers KA; Division of Hematology, The Ohio State University, Columbus, Ohio, USA.
  • Grever M; Division of Hematology, The Ohio State University, Columbus, Ohio, USA.
  • Ruz P; Cardio-Oncology Program, Division of Cardiology, The Ohio State University Medical Center, Columbus, Ohio, USA.
  • Bhat S; Division of Hematology, The Ohio State University, Columbus, Ohio, USA.
  • Dickerson T; Department of Pharmacy, James Cancer Hospital and Solove Research Institute, Columbus, Ohio, USA.
  • Byrd JC; Department of Medicine, University of Cincinnati, Cincinnati, Ohio, USA.
  • Woyach J; Division of Hematology, The Ohio State University, Columbus, Ohio, USA.
  • Addison D; Cardio-Oncology Program, Division of Cardiology, The Ohio State University Medical Center, Columbus, Ohio, USA.
JACC CardioOncol ; 5(5): 570-590, 2023 Oct.
Article em En | MEDLINE | ID: mdl-37969643

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2023 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2023 Tipo de documento: Article